In deciding whether it is time to stop hormone therapy, in addition to the patient's age we need to consider her preferences, symptoms, quality of life, time since menopause, hysterectomy status, and personal risks of osteoporosis, breast cancer, heart disease, stroke, and venous thromboembolism. This article presents the evidence for and against extending hormone therapy and a guide for making this highly individualized and shared decision.
CITATION STYLE
Lipold, L. D., Batur, P., & Kagan, R. (2016). Is there a time limit for systemic menopausal hormone therapy? Cleveland Clinic Journal of Medicine, 83(8). https://doi.org/10.3949/ccjm.83a.15161
Mendeley helps you to discover research relevant for your work.